GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (STU:IL3) » Definitions » Market Cap

Integra Lifesciences Holdings (STU:IL3) Market Cap : €1,771 Mil (As of Dec. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Integra Lifesciences Holdings's share price for the quarter that ended in Sep. 2024 was €16.1. Integra Lifesciences Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 77 Mil. Therefore, Integra Lifesciences Holdings's market cap for the quarter that ended in Sep. 2024 was €1,242 Mil.

Integra Lifesciences Holdings's quarterly market cap declined from Mar. 2024 (€2,520 Mil) to Jun. 2024 (€2,079 Mil) and declined from Jun. 2024 (€2,079 Mil) to Sep. 2024 (€1,242 Mil).

Integra Lifesciences Holdings's annual market cap declined from Dec. 2021 (€5,167 Mil) to Dec. 2022 (€4,392 Mil) and declined from Dec. 2022 (€4,392 Mil) to Dec. 2023 (€3,080 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Integra Lifesciences Holdings's Enterprise Value for Today is €3,405 Mil.


Integra Lifesciences Holdings Market Cap Historical Data

The historical data trend for Integra Lifesciences Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Market Cap Chart

Integra Lifesciences Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,465.24 4,554.20 5,166.76 4,391.84 3,079.86

Integra Lifesciences Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,863.85 3,079.86 2,519.97 2,079.22 1,241.86

Competitive Comparison of Integra Lifesciences Holdings's Market Cap

For the Medical Devices subindustry, Integra Lifesciences Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integra Lifesciences Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Integra Lifesciences Holdings's Market Cap falls into.



Integra Lifesciences Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Integra Lifesciences Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€39.4*78.169
=€3,080

Integra Lifesciences Holdings's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€16.1*77.134
=€1,242

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integra Lifesciences Holdings  (STU:IL3) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Integra Lifesciences Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Integra Lifesciences Holdings Business Description

Traded in Other Exchanges
Address
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings Headlines

No Headlines